Fitch Ratings isn’t the only one taking a hard look at Teva Pharmaceutical Industries (TEVA). Late yesterday, Fitch cut Teva’s debt rating to junk, making it the first of the three major credit ratings agencies to strip the generic drug maker of its investment-grade status. According to Theflyonthewall.com, HSBC analyst Steve McGarry cut his rating […]